Early invasive strategies for acute coronary syndromes
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Early coronary angiography and percutaneous or operative revascularization is now the treatment of choice for both ST- and non-ST-segment elevation acute coronary syndromes (ACS). In non-ST-segment elevation ACS this strategy produces a 18% to 22% reduction in ischemic outcomes at 6 months and prevents 1.7 deaths, 2.0 nonfatal infarcts and 20 readmissions per 100 treated patients at 1-year follow-up. Early angiography allows definition of coronary anatomy and assessment of left ventricular function, both important predictors of long-term risk. Intracoronary stenting and intravenous glycoprotein IIb/IIIa antagonists have improved outcome in percutaneous revascularization and should be used in the majority of ACS patients undergoing PCI. Initial costs are higher with an early invasive strategy; however, these are offset by reductions in rehospitalizations and later ischemic complications.
- The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993, 329:673–682. CrossRef
- Grines CL, Cox DA, Stone GW, et al.: Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999, 341:1949–1956. CrossRef
- Stone GW, Grines CL, Cox DA, et al.: A prospective, multicenter, international randomized trial comparing four perfusion strategies in acute myocardial infarction: Principal report of the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol. 2001, 37:342A.
- Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001, 344:1879–1887. First trial to compare early invasive and conservative strategies in ACS patients treated with the intravenous GP IIb/IIIa antagonists, tirofiban. CrossRef
- The FRISC II Investigators: Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999, 354:708–715. CrossRef
- Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice. Circulation. 2000, 102:1193–1209. Important guidelines on the management of ACS.
- Theroux P, Fuster V: Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 1998, 97:1195–1206.
- Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000, 101:570–580.
- Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of lowmolecular- weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447–452. CrossRef
- Antman EM, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina/ non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999, 100:1593–1601.
- Theroux P, Waters D, Lam J, et al.: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992, 327:141–145. CrossRef
- Bijsterveld NR, Moons AH, Meijers JC, et al.: Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and lowmolecular- weight heparin. J Am Coll Cardiol. 2002, 39:811–817. CrossRef
- Yusuf S, Flather M, Pogue J, et al.: Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998, 352:507–514. CrossRef
- The TIMI IIIB Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994, 89:1545–1556. Initial trial comparing early invasive and conservative strategies.
- Anderson HV, Cannon CP, Stone PH, et al.: One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. [erratum appears in J Am Coll Cardiol 2000, 35:263]. J Am Coll Cardiol. 1995, 26:1643–1650. CrossRef
- Boden WE, O’Rourke RA, Crawford MH, et al.: Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998, 338:1785–1792. CrossRef
- Wallentin L, Lagerqvist B, Husted S, et al.: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000, 356:9–16. First trial to demonstrate a benefit of early angiography in ACS. CrossRef
- Kiemeneij F, Serruys PW, Macaya C, et al.: Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol. 2001, 37:1598–1603. CrossRef
- Montalescot G, Barragan P, Wittenberg O, et al.: Angioplasty AIAbD, Stenting in Myocardial Infarction Regarding A, Long- Term F-u. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001, 344:1895–1903. CrossRef
- Loubeyre C, Morice M, Lefevre T, et al.: A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol. 2002, 39:15–21. CrossRef
- Ryan TJ, Antman EM, Brooks NH, et al.: 1999 update: ACC/ AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 1999, 100:1016–1030.
- Boersma E, Pieper KS, Steyerberg EW, et al.: Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation. 2000, 101:2557–2567.
- Ohman EM, Armstrong PW, Christenson RH, et al.: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996, 335:1333–1341. CrossRef
- Kaul P, Fu Y, Chang WC, Harrington RA, et al.: Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON- A and GUSTO IIb Investigators. J Am Coll Cardiol. 2001, 38:64–71. CrossRef
- Morrow DA, Cannon CP, Rifai N, et al.: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non- ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001, 286:2405–2412. CrossRef
- Holmvang L, Luscher MS, Clemmensen P, et al.: Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). Circulation. 1998, 98:2004–2009.
- Antman EM, Cohen M, Bernink PJ, et al.: The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000, 284:835–842. CrossRef
- Roe MT, Harrington RA, Prosper DM, et al.: Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. Circulation. 2000, 102:1101–1106.
- Goldstein JA, Demetriou D, Grines CL, et al.: Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000, 343:915–922. CrossRef
- Kleber FX, Dopfmer S, Thieme T: Invasive strategies to discriminate stable and unstable coronary plaques. Eur Heart J 1998, 19:C44-C49.
- Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al.: Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation. 1999, 99:1965–1971.
- Pijls NH, De Bruyne B, Peels K, et al.: Measurement of fractional flow reserve to assess the functional severity of coronary- artery stenoses. N Engl J Med 1996, 334:1703–1708. CrossRef
- The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994, 330:956–961. CrossRef
- The ESPRIT Investigators: Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet. 2000, 356:2037–2044. CrossRef
- Boersma E, Harrington RA, Moliterno DJ, et al.: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002, 359:189–198. CrossRef
- Roffi M, Chew DP, Mukherjee D, et al.: Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001, 104:2767–2771.
- Topol EJ, Moliterno DJ, Herrmann HC, et al.: Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001, 344:1888–1894. CrossRef
- The GUSTO IV Investigators: Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet. 2001, 357:1915–1924. CrossRef
- Yusuf S, Zhao F, Mehta SR, et al.: The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001, 345:494–502. CrossRef
- Mehta SR, Yusuf S, Peters RJ, et al.: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001, 358:527–533. CrossRef
- Hirsh J, Anand SS, Halperin JL, Fuster V: Guide to anticoagulant therapy: Heparin: a statement for healthcare professionals from the American Heart Association. Circulation. 2001, 103:2994–3018.
- Weitz JI, Buller HR: Direct Thrombin Inhibitors in Acute Coronary Syndromes: present and future. Circulation. 2002, 105:1004–1011. CrossRef
- Bittl JA, Chaitman BR, Feit F, et al.: Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J. 2001, 142:952–959. CrossRef
- Bittl JA, Strony J, Brinker JA, et al.: Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med 1995, 333:764–769. CrossRef
- Zhao X-Q, Theroux P, Snapinn SM, Sax FL: Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). Circulation. 1999, 100:1609–1615.
- Stone GW, Cox D, Garcia E, et al.: Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001, 104:636–641.
- Baim DS, Wahr D, George B, et al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002:13–18.
- Silva JA, Ramee SR, Cohen DJ, et al.: Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. Am Heart J 2001, 141:353–359. CrossRef
- Early invasive strategies for acute coronary syndromes
Current Cardiology Reports
Volume 4, Issue 4 , pp 334-340
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links